Search - tctmd.com

Displaying 1 - 20 of 94

Sort: Relevancy | Date

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Pediatric Hypertension On the Rise Globally

Todd Neale

November 28, 2025

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

News Daily News

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

L.A. McKeown

August 07, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Caitlin E. Cox

April 17, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Daily News

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Todd Neale

January 09, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

Advertisement

JACC Debuts Data Digest on CV Health in the United States

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Pediatric Hypertension On the Rise Globally

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

TCTMD’s Top 10 Most Popular Stories for July 2025

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review

Top General Cardiology and Prevention News of 2024

November 2024 Dispatch for the CV Team

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Will Semaglutide Change Cardiac Surgery? It Already Has

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content